Huang et al [42] found that elevated levels of HMGA2 have been potentially linked to diminished overall survival among individuals diagnosed with head and neck cancer, hepatocellular carcinoma, renal cancer, and pancreatic ductal adenocarcinoma. Here, HMGA2 is linked to hepatocellular carcinoma.